Iron metabolism

Jun 06, 2018

Protagonist Therapeutics to Present at the 2018 JMP Securities Life Sciences Conference

May 17, 2018

Protagonist Therapeutics Announces Two Oral Presentations Accepted for 23rd Congress of the European Hematology Association

Dec 14, 2017

Protagonist Therapeutics Announces Final Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300

Dec 04, 2017

Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

Dec 04, 2017

Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

Nov 07, 2017

The Renal Anemia Market is on the Cusp of Change Beginning with the FDA Approval of Keryx Biopharmaceutical's Auryxia for the Treatment of Iron Deficiency Anemia (IDA) in Adults with Chronic Kidney Disease, Not on Dialysis (CKD-ND)

Nov 01, 2017

Protagonist Therapeutics to Present at the Stifel 2017 Healthcare Conference

Sep 20, 2017

Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300

Sep 11, 2017

Protagonist Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference